Ahn Sun Tae, Kim Young-Sang, Yu Sung Hoon, Chung Yoon-Sok
Department of Urology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Department of Family Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
World J Mens Health. 2025 Jul;43(3):492-509. doi: 10.5534/wjmh.240266. Epub 2025 Feb 10.
The Korean Society of Men's Health and Aging (KSMHA) acknowledges the necessity for an updated statement on testosterone therapy driven by evolving clinical practices and new research findings. The primary purpose of this position statement is to provide a tailored, evidence-based framework that aligns with international best practices while addressing the unique needs of the Korean population. Additionally, this statement addresses the growing recognition of both organic and functional hypogonadism, particularly given the rising rates of obesity and metabolic syndrome, which affect testosterone levels and overall health. The position statement addresses key areas, including the clinical and laboratory diagnosis of male hypogonadism, with a focus on appropriate cut-off values for testosterone levels in Korean men, and provides guidance on assessing treatment outcomes. In this statement, we present an objective position on testosterone therapy based on recent studies that have carefully evaluated its effectiveness and safety. By providing a tailored framework for the management of male hypogonadism, KSMHA aims to enhance patient care and align Korean practices with global standards.
韩国男性健康与衰老学会（KSMHA）认识到，随着临床实践的不断发展和新研究结果的出现，有必要更新关于睾酮治疗的声明。本立场声明的主要目的是提供一个量身定制的、基于证据的框架，该框架既符合国际最佳实践，又能满足韩国人群的独特需求。此外，鉴于肥胖和代谢综合征的发病率不断上升，这两种疾病会影响睾酮水平和整体健康，本声明还涉及对器质性和功能性性腺功能减退的日益认识。该立场声明涉及关键领域，包括男性性腺功能减退的临床和实验室诊断，重点关注韩国男性睾酮水平的适当临界值，并提供评估治疗效果的指导。在本声明中，我们基于近期对睾酮治疗的有效性和安全性进行仔细评估的研究，提出了关于睾酮治疗的客观立场。通过为男性性腺功能减退的管理提供量身定制的框架，KSMHA旨在提高患者护理水平，并使韩国的实践与全球标准保持一致。
